Arovella Therapeutics Limited - Australian Company Profile

What does Arovella Therapeutics Limited do?

Arovella Therapeutics is a Public Company that generates the majority of its income from the Pharmaceutical Product Manufacturing industry.

In 2025 the company generated total revenue of $3,830,000 including sales and other revenue. The exact number of employees for this organisation is not available.

The Chief Executive of Arovella Therapeutics is Unknown Michael James Baker whose official title is CHIEF EXECUTIVE OFFICER. The Chairman of Arovella Therapeutics is Dr Elizabeth Stoner whose official title is Interim Non-Executive Chairman.

Thousands of companies, hundreds of industries

Get strategic insights and analysis on 700+ industries in Australia and thousands of companies with an annual membership.

Get in Touch

Arovella TherapeuticsLimted is a pharmaceutical developer focusing on the oncology and central nervous system (CNS) areas. The company is based in Melbourne Victoria, however opperates internationally with patents and contracts with counties such as Japan and the USA. Arovella currently has the following treatment and products under its brand: iNKT Cell Therapy Platform - Supplied by the Imperial College London and used in the treatment of blood cancers DKK1-Car-iNKT CAR19-iNKT + CF33-CD19 Anagrelide - Used in the reduction of platelets and lowering of thrombotic risk in myeloproliferative diseases associated with high platelet counts. ZolpiMist - An oral based spray containing zolpidem tartrate used in aiding sleep quality.

Enterprise Profiles - table of contents

Enterprise Details

Get a high-level overview of Arovella Therapeutics Limited, including registered business details, an enterprise synopsis, SWOT analysis and main brands and products.

Key Personnel

We outline the key personnel at Arovella Therapeutics Limited by position type and title.

Enterprise Financials

Get a full view of Arovella Therapeutics Limited’s financials, including Profit and Loss Account (Revenue, Interest, Profit and Loss, and Audit Fees) and Balance Sheet (Current Assets, Non-Current Assets, Current Liabilities, Non-Current Liabilities, Shareholders’ Equity), as well as Number of Employees, Number of Share on Issue, Market Capitalisation and Earnings per Share where available. Note: we do not provide a full financial details for all company profiles.

Growth & Ratios

Get a clearer picture of Arovella Therapeutics Limited’s performance, with key financial ratios and data on financial growth.

Operating Segments

Understand the main operating divisions of Arovella Therapeutics Limited, including Revenue and Assets under each Segment, Industries and Geographic Locations Arovella Therapeutics Limited operates in.

Competitor Benchmarking

Compare Arovella Therapeutics Limited’s financial ratios and growth to peers in their industries of operation for a clearer picture of performance.

Major Shareholders

We outline the ultimate parent and largest shareholders of Arovella Therapeutics Limited.

Subsidiaries

View a list of Arovella Therapeutics Limited’s associated companies, holding company, joint ventures and trusts, both domestic and international.

History

Find out more about the history and background of Arovella Therapeutics Limited, including founding information, past announcements, mergers and major projects.